Cargando…
Novel oncolytic chimeric orthopoxvirus causes regression of pancreatic cancer xenografts and exhibits abscopal effect at a single low dose
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) has been increasing by 0.5% per year in the United States. PDAC portends a dismal prognosis and novel therapies are needed. This study describes the generation and characterization of a novel oncolytic chimeric orthopoxvirus for the treatment of pa...
Autores principales: | O’Leary, Michael P., Choi, Audrey H., Kim, Sang-In, Chaurasiya, Shyambabu, Lu, Jianming, Park, Anthony K., Woo, Yanghee, Warner, Susanne G., Fong, Yuman, Chen, Nanhai G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918769/ https://www.ncbi.nlm.nih.gov/pubmed/29699566 http://dx.doi.org/10.1186/s12967-018-1483-x |
Ejemplares similares
-
A Novel Oncolytic Chimeric Orthopoxvirus Encoding Luciferase Enables Real-Time View of Colorectal Cancer Cell Infection
por: O’Leary, Michael P., et al.
Publicado: (2018) -
A Novel Chimeric Poxvirus Encoding hNIS Is Tumor-Tropic, Imageable, and Synergistic with Radioiodine to Sustain Colon Cancer Regression
por: Warner, Susanne G., et al.
Publicado: (2019) -
Toward comprehensive imaging of oncolytic viroimmunotherapy
por: Chaurasiya, Shyambabu, et al.
Publicado: (2021) -
A chimeric poxvirus with J2R (thymidine kinase) deletion shows safety and anti-tumor activity in lung cancer models
por: Chaurasiya, Shyambabu, et al.
Publicado: (2019) -
Endogenous Akt Activity Promotes Virus Entry and Predicts Efficacy of Novel Chimeric Orthopoxvirus in Triple-Negative Breast Cancer
por: Choi, Audrey H., et al.
Publicado: (2018)